fingolimod hydrochloride has been researched along with ferrostatin-1 in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (ferrostatin-1) | Trials (ferrostatin-1) | Recent Studies (post-2010) (ferrostatin-1) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 176 | 0 | 175 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, A; Liu, Z; Ma, H; Tian, F; Wang, H; Yang, W; Zhong, Y | 1 |
1 other study(ies) available for fingolimod hydrochloride and ferrostatin-1
| Article | Year |
|---|---|
FTY720 induces ferroptosis and autophagy via PP2A/AMPK pathway in multiple myeloma cells.
Topics: Amino Acid Transport System y+; AMP-Activated Protein Kinases; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Ferroptosis; Fingolimod Hydrochloride; Humans; Multiple Myeloma; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Protein Phosphatase 2; Signal Transduction | 2020 |